1. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Issue 10 (October 1987) Authors: Dasgupta, B; Duke, O; Kyle, V; Macfarlane, D G; Hazleman, B L; Panayi, G S Journal: Annals of the rheumatic diseases Issue: Volume 46:Issue 10(1987) Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of inflammation in the rheumatoid knee joint: correlation between clinical, radioisotopic, and thermographic methods. Issue 4 (April 1986) Authors: de Silva, M; Kyle, V; Hazleman, B; Salisbury, R; Page Thomas, P; Wraight, P Journal: Annals of the rheumatic diseases Issue: Volume 45:Issue 4(1986) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. Issue 5 (May 1989) Authors: Kyle, V; Coughlan, R J; Tighe, H; Waldmann, H; Hazleman, B L Journal: Annals of the rheumatic diseases Issue: Volume 48:Issue 5(1989) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Issue 8 (August 1989) Authors: Kyle, V; Cawston, T E; Hazleman, B L Journal: Annals of the rheumatic diseases Issue: Volume 48:Issue 8(1989) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Giant cell arteritis of myometrial and axillary arteries and polymyalgia rheumatica. Issue 3 (March 1987) Authors: Kyle, V; Dutoit, S H; Elias-Jones, J; Hazleman, B Journal: Annals of the rheumatic diseases Issue: Volume 46:Issue 3(1987) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis. Issue 6 (June 1987) Authors: Smith, A J; Kyle, V; Cawston, T E; Hazleman, B L Journal: Annals of the rheumatic diseases Issue: Volume 46:Issue 6(1987) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice. Issue 6492 (10th August 1985) Authors: Kyle, V; Silverman, B; Silman, A; King, H; Oswald, N; Reiss, B; Hazleman, B Journal: BMJ Issue: Volume 291:Issue 6492(1985) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prostaglandin E1 vasospastic disease and thermography. Issue 2 (February 1985) Authors: Kyle, V; Parr, G; Salisbury, R; Thomas, P P; Hazleman, B Journal: Annals of the rheumatic diseases Issue: Volume 44:Issue 2(1985) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rarity of synovitis in polymyalgia rheumatica. Issue 3 (March 1990) Authors: Kyle, V; Tudor, J; Wraight, E P; Gresham, G A; Hazleman, B L Journal: Annals of the rheumatic diseases Issue: Volume 49:Issue 3(1990) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. Issue 6721 (10th February 1990) Authors: Kyle, V; Hazelman, B L Journal: BMJ Issue: Volume 300:Issue 6721(1990) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗